Ergoteles LLC I Bio, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $160.0 $44,464 - $30.9 Million	-193,324 Reduced 18.79%	835,436 $142,000
Q2 2022 Aug 12, 2022	BUY	$0.23 - $0.46 $236,614 - $473,229	1,028,760 New	1,028,760 $272,000
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $37,842 - $54,264	-35,700 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$1.22 - $1.65 $43,554 - $58,905	35,700 New	35,700 $54,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.